Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan S Jensen

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Current Cardiology Reviews|January 13, 2010
The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus IntracoronaryAllan Iversen, Søren Galatius, Jan S Jensen
Acta Diabetologica|October 18, 2017
Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients-the Thousand & 1 StudySimone Theilade, Peter Rossing, Jan S Jensen, et al.
European Journal of Preventive Cardiology|April 1, 2011
Intensity versus duration of cycling, impact on all-cause and coronary heart disease mortality: the Copenhagen City Heart StudyPeter Schnohr, Jacob L Marott, Jan S Jensen, et al.
Drugs & Aging|May 6, 2011
Impact of abciximab in elderly patients with high-risk acute coronary syndrome undergoing percutaneous coronary intervention: an observational registry studyAllan Z Iversen, Soeren Galatius, Sune Pedersen, et al.
International Journal of Cardiology|August 21, 2015
Plasma pro-brain natriuretic peptide and electrocardiographic changes in combination improve risk prediction in persons without known heart diseasePeter G Jørgensen, Jan S Jensen, Merete Appleyard, et al.
European Journal of Endocrinology|March 9, 2016
suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal diseaseSimone Theilade, Peter Rossing, Jesper Eugen-Olsen, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Retinopathy is associated with impaired myocardial function assessed by advanced echocardiography in type 1 diabetes patients - The Thousand & 1 StudyNina Nouhravesh, Henrik U Andersen, Jan S Jensen, et al.
The International Journal of Cardiovascular Imaging|August 26, 2018
Prognostic importance of mechanical dyssynchrony in predicting heart failure development after ST-segment elevation myocardial infarctionInge Noringriis, Daniel Modin, Sune H Pedersen, et al.
JACC. Cardiovascular Imaging|February 19, 2018
Relationship Between Left Atrial Functional Measures and Incident Atrial Fibrillation in the General Population: The Copenhagen City Heart StudyFlemming J Olsen, Rasmus Møgelvang, Gorm B Jensen, et al.
Critical Care (London, England)|February 26, 2013
Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholaminesSisse R Ostrowski, Sune H Pedersen, Jan S Jensen, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Current Cardiology Reviews|January 13, 2010
The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus IntracoronaryAllan Iversen, Søren Galatius, Jan S Jensen
Acta Diabetologica|October 18, 2017
Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients-the Thousand & 1 StudySimone Theilade, Peter Rossing, Jan S Jensen, et al.
European Journal of Preventive Cardiology|April 1, 2011
Intensity versus duration of cycling, impact on all-cause and coronary heart disease mortality: the Copenhagen City Heart StudyPeter Schnohr, Jacob L Marott, Jan S Jensen, et al.
Drugs & Aging|May 6, 2011
Impact of abciximab in elderly patients with high-risk acute coronary syndrome undergoing percutaneous coronary intervention: an observational registry studyAllan Z Iversen, Soeren Galatius, Sune Pedersen, et al.
International Journal of Cardiology|August 21, 2015
Plasma pro-brain natriuretic peptide and electrocardiographic changes in combination improve risk prediction in persons without known heart diseasePeter G Jørgensen, Jan S Jensen, Merete Appleyard, et al.
European Journal of Endocrinology|March 9, 2016
suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal diseaseSimone Theilade, Peter Rossing, Jesper Eugen-Olsen, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Retinopathy is associated with impaired myocardial function assessed by advanced echocardiography in type 1 diabetes patients - The Thousand & 1 StudyNina Nouhravesh, Henrik U Andersen, Jan S Jensen, et al.
The International Journal of Cardiovascular Imaging|August 26, 2018
Prognostic importance of mechanical dyssynchrony in predicting heart failure development after ST-segment elevation myocardial infarctionInge Noringriis, Daniel Modin, Sune H Pedersen, et al.
JACC. Cardiovascular Imaging|February 19, 2018
Relationship Between Left Atrial Functional Measures and Incident Atrial Fibrillation in the General Population: The Copenhagen City Heart StudyFlemming J Olsen, Rasmus Møgelvang, Gorm B Jensen, et al.
Critical Care (London, England)|February 26, 2013
Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholaminesSisse R Ostrowski, Sune H Pedersen, Jan S Jensen, et al.
Pageof 7